Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 5 Neoplasm Metastasis 5 Pancreatic Neoplasms 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 40 Paclitaxel 30 Bevacizumab 16 Gemcitabine 14 Cyclophosphamide 14 liposomal doxorubicin 13 Taxes 12 Topotecan 11 Cisplatin 11 Docetaxel 7 veliparib 6 pembrolizumab 6 olaparib 6 Doxorubicin 6 Magnetic Resonance Spectroscopy 5 Albumin-Bound Paclitaxel 5 sargramostim 4 fludarabine 4 aldesleukin 4 Specimen Handling 4 Oxaliplatin 4 Leucovorin 4 Immunoglobulin G 4 Filgrastim 4 Drug Therapy 4 Disulfides 4 Biopsy 4 talazoparib 3 mirvetuximab soravtansine 3 Radiotherapy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Fallopian Tube Neoplasms × demcizumab × Clear all

NCT01952249 2020-09-09

SIERRA

Mereo BioPharma

Phase 1 Terminated

Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡